Attached files
file | filename |
---|---|
EX-31.1 - EX-31.1 - IVERIC bio, Inc. | a2223280zex-31_1.htm |
EX-10.7 - EX-10.7 - IVERIC bio, Inc. | a2223280zex-10_7.htm |
EX-10.4 - EX-10.4 - IVERIC bio, Inc. | a2223280zex-10_4.htm |
EX-32.2 - EX-32.2 - IVERIC bio, Inc. | a2223280zex-32_2.htm |
EX-32.1 - EX-32.1 - IVERIC bio, Inc. | a2223280zex-32_1.htm |
EX-31.2 - EX-31.2 - IVERIC bio, Inc. | a2223280zex-31_2.htm |
EX-10.8 - EX-10.8 - IVERIC bio, Inc. | a2223280zex-10_8.htm |
EX-10.22 - EX-10.22 - IVERIC bio, Inc. | a2223280zex-10_22.htm |
EX-10.24 - EX-10.24 - IVERIC bio, Inc. | a2223280zex-10_24.htm |
EX-10.23 - EX-10.23 - IVERIC bio, Inc. | a2223280zex-10_23.htm |
EXCEL - IDEA: XBRL DOCUMENT - IVERIC bio, Inc. | Financial_Report.xls |
10-K - 10-K - IVERIC bio, Inc. | a2223280z10-k.htm |
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
- (1)
- Registration
Statement (Form S-8 No. 333-193694) pertaining to the 2013 Stock Incentive Plan of Ophthotech Corporation effective
January 31, 2014,
- (2)
- Registration Statement (Form S-8 No. 333-191767) pertaining to the 2013 Stock Incentive Plan and Amended and Restated 2007 Stock Incentive Plan of Ophthotech Corporation effective October 16, 2013,
of our reports dated March 2, 2015, with respect to the financial statements of Ophthotech Corporation and the effectiveness of internal control over financial reporting of Ophthotech Corporation, included in this Annual Report (Form 10-K) of Ophthotech Corporation for the year ended December 31, 2014.
/s/
Ernst & Young LLP
MetroPark, New Jersey
March 2, 2015
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM